MétaCan
Menu
Back to cohort
Record W4285807482 · doi:10.1002/jia2.25917

Clinical and population‐based study design considerations to accelerate the investigation of new antiretrovirals during pregnancy

2022· article· en· W4285807482 on OpenAlexaff
Sean S. Brummel, Jeff Stringer, Ed Mills, Camlin Tierney, Ellen C. Caniglia, Angela Colbers, H. Benjamin, Brookie M. Best, Myriam El Gaaloul, Sharon L. Hillier, Gonzague Jourdain, Saye Khoo, Lynne Mofenson, Landon Myer, Sharon Nachman, Lynda Stranix‐Chibanda, Polly Clayden, Memory Sachikonye, Shahin Lockman

Bibliographic record

VenueJournal of the International AIDS Society · 2022
Typearticle
Languageen
FieldMedicine
TopicPregnancy and Medication Impact
Canadian institutionsMembrane Reactor Technologies (Canada)
FundersEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Institute of Allergy and Infectious DiseasesNational Institutes of Health
KeywordsMedicinePregnancyObservational studyDosingPopulationClinical endpointRandomized controlled trialClinical trialClinical study designAdverse effectGestational ageResearch designIntensive care medicineObstetricsPediatricsInternal medicineEnvironmental health

Abstract

fetched live from OpenAlex

INTRODUCTION: Pregnant women are routinely excluded from clinical trials, leading to the absence or delay in even the most basic pharmacokinetic (PK) information needed for dosing in pregnancy. When available, pregnancy PK studies use a small sample size, resulting in limited safety information. We discuss key study design elements that may enhance the timely availability of pregnancy data, including the role and timing of randomized controlled trials (RCTs) to evaluate pregnancy safety; efficacy and safety outcome measures; stand-alone protocols, platform trials, single arm studies, sample size and the effect that follow-up time during gestation has on analysis interpretations; and observational studies. DISCUSSION: Pregnancy PK should be studied during drug development, after dosing in non-pregnant persons is established (unless non-clinical or other data raise pregnancy concerns). RCTs should evaluate the safety during pregnancy of priority new HIV agents that are likely to be used by large numbers of females of childbearing age. Key endpoints for pregnancy safety studies include birth outcomes (prematurity, small for gestational age and stillbirth) and neonatal death, with traditional adverse events and infant growth also measured (congenital anomalies are best studied through surveillance). We recommend that viral efficacy be studied as a secondary endpoint of pregnancy RCTs, once PK studies confirm adequate drug exposure in pregnancy. RCTs typically use a stand-alone protocol for new agents. In contrast, master protocols using a platform design can add agents over time, possibly speeding safety data ascertainment. To speed accrual, stand-alone pregnancy trial protocols can include pre-specified starting rules based upon adequate PK levels in pregnancy; and seamless master protocols or platform trials can include a pregnancy PK and safety component. When RCTs are unethical or cost-prohibitive, observational studies should be conducted, preferably using target trial emulation to avoid bias. CONCLUSIONS: Pregnancy PK needs to be obtained earlier in drug evaluation. Timely RCTs are needed to understand safety in pregnancy for high-priority new HIV agents. RCTs that enrol pregnant women should focus on outcomes unique to pregnancy, and observational studies should focus on questions that RCTs are not equipped to answer.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.566
metaresearch head score (Gemma)0.589
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesMetaresearch
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Theoretical or conceptual · Consensus signal: none
GenreCandidate signal: Methods · Consensus signal: none
Teacher disagreement score0.566
Threshold uncertainty score0.536

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.5660.589
Meta-epidemiology (narrow)0.0020.003
Meta-epidemiology (broad)0.0050.006
Bibliometrics0.0040.006
Science and technology studies0.0020.003
Scholarly communication0.0080.008
Open science0.0050.005
Research integrity0.0070.007
Insufficient payload (model declined to judge)0.0190.004

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.116
GPT teacher head0.378
Teacher spread0.261 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

Study designTheoretical or conceptual
Domainnot available
GenreMethods

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations12
Published2022
Admission routes1
Has abstractyes

Explore more

Same venueJournal of the International AIDS SocietySame topicPregnancy and Medication ImpactFrench-language works237,207